Cost-utility analysis of dapagliflozin for the treatment of symptomatic chronic heart failure in Spain
Abstract Background The objective of this study was to perform a cost-utility analysis of dapagliflozin, as an add-on therapy to standard of care (SoC), compared with SoC, for patients with symptomatic chronic heart failure (HF) in Spain, including patients with reduced and preserved ejection fracti...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-07-01
|
| Serija: | BMC Health Services Research |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s12913-025-13089-7 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|